Phase II trial of apatinib in the treatment of metastatic penile cancer
Not Applicable
- Conditions
- phase II ,single arm
- Registration Number
- JPRN-UMIN000021849
- Lead Sponsor
- Fudan University Shanghai Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 26
Inclusion Criteria
Not provided
Exclusion Criteria
1) Usage of experimental drugs 2) History of serious drug allergy 3) uncontrolled hemorrhage 4) PS>1 5) heart failure 6) Double cancer 7) Coexisting severe medical conditions 8) Mental disease 9) Judged as inappropriate to participate this trial by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method